SELECT+ Trademark

Trademark Overview

On Tuesday, August 23, 2016, a trademark application was filed for SELECT+ with the United States Patent and Trademark Office. The USPTO has given the SELECT+ trademark a serial number of 87147112. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, December 20, 2019. This trademark is owned by Calimmune, Inc.. The SELECT+ trademark is filed in the Pharmaceutical Products category with the following description:

Chemoselective agents for gene therapy
select+

General Information

Serial Number87147112
Word MarkSELECT+
Filing DateTuesday, August 23, 2016
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, December 20, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2017

Trademark Statements

Goods and ServicesChemoselective agents for gene therapy
Pseudo MarkSELECT PLUS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, December 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCalimmune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTucson, AZ 85711
Party NameCalimmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTucson, AZ 85711

Trademark Events

Event DateEvent Description
Friday, December 20, 2019ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Friday, December 20, 2019ABANDONMENT - AFTER PUBLICATION
Thursday, December 19, 2019TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, August 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 26, 2019EXTENSION 5 GRANTED
Thursday, August 22, 2019EXTENSION 5 FILED
Monday, August 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 22, 2019TEAS EXTENSION RECEIVED
Thursday, February 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 26, 2019EXTENSION 4 GRANTED
Tuesday, February 26, 2019EXTENSION 4 FILED
Tuesday, February 26, 2019TEAS EXTENSION RECEIVED
Thursday, August 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 14, 2018EXTENSION 3 GRANTED
Tuesday, August 14, 2018EXTENSION 3 FILED
Tuesday, August 14, 2018TEAS EXTENSION RECEIVED
Friday, February 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 21, 2018EXTENSION 2 GRANTED
Wednesday, February 21, 2018EXTENSION 2 FILED
Wednesday, February 21, 2018TEAS EXTENSION RECEIVED
Saturday, August 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 24, 2017EXTENSION 1 GRANTED
Thursday, August 24, 2017EXTENSION 1 FILED
Thursday, August 24, 2017TEAS EXTENSION RECEIVED
Wednesday, March 8, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, December 4, 2016ASSIGNED TO EXAMINER
Saturday, August 27, 2016NOTICE OF PSEUDO MARK E-MAILED
Friday, August 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 26, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

select therapy gene agents chemoselective